Coronavirus
Bahrain approves emergency use for Regeneron COVID-19 medicine: BNA
Bahrain on Wednesday approved the emergency use for regn-cov2 medicine, Regeneron Pharmaceuticals Inc’s and Roche’s newly authorized COVID-19 antibody combination, as part of its coronavirus treatment protocol to treat existing cases with mild and moderate symptoms, the state news agency (BNA) reported.
For the latest headlines, follow our Google News channel online or via the app.
The report said updating the corona treatment protocol in the kingdom would reduce symptoms complications.
Read more:
Watch: Hundreds of cars line up to enter Bahrain at King Fahd causeway as it reopens
Bahrain, Kuwait strongly condemn Lebanon’s FM statements on Saudi Arabia and GCC
Bahrain restricts access for unvaccinated as COVID-19 cases spike
Also Read
-
Watch: Hundreds of cars line up to enter Bahrain at King Fahd causeway as it reopens
Hundreds of cars lined up the King Fahd causeway to enter Bahrain as thousands of citizens and residents of Saudi Arabia are expected to cross the ... Gulf -
Bahrain, Kuwait strongly condemn Lebanon’s FM statements on Saudi Arabia and GCC
The Ministries of Foreign Affairs of Kuwait and Bahrain expressed their strong condemnation of the offensive statements made by the Minister of ... Gulf -
Bahrain restricts access for unvaccinated as COVID-19 cases spike
Bahrain said on Thursday it would restrict access to most public venues to immunized people only after coronavirus cases hit a record high in the Gulf ... Coronavirus
